(VIANEWS) - Huntington Bancshares (HBAN), iRadimed Corporation (IRMD), ArcBest Corporation (ARCB) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Huntington Bancshares (HBAN)
37.6% sales growth and 6.92% return on equity
Huntington Bancshares Incorporated operates as a holding company for The Huntington National Bank that provides commercial, small business, consumer, and mortgage banking services.
Huntington Bancshares's sales growth this year is anticipated to be 24.8% and 13.1% for next year.
Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 4.69B for the twelve trailing months.
Volume
Today's last reported volume for Huntington Bancshares is 6319610 which is 50.85% below its average volume of 12858600.
Huntington Bancshares's sales growth is a negative 0% for the ongoing quarter and 37.6% for the next. The company's growth estimates for the present quarter and the next is 22.2% and 25.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.92%.
Volatility
Huntington Bancshares's last day, last week, and last month's current volatility was 2.20%, 1.17%, and 1.21%, respectively.
Huntington Bancshares's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.21% (day), 2.20% (last week), and 2.33% (last month), respectively.
Huntington Bancshares's Stock Yearly Top and Bottom Value
Huntington Bancshares's stock is valued at $16.49 at 06:22 EST, below its 52-week high of $16.91 and way above its 52-week low of $9.66.
Huntington Bancshares's Moving Average
Huntington Bancshares's worth is higher than its 50-day moving average of $15.52 and higher than its 200-day moving average of $15.10.2. iRadimed Corporation (IRMD)
25.8% sales growth and 7.41% return on equity
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.
iRadimed Corporation's sales growth this year is expected to be 26.6% and 12.5% for next year.
Year-on-year quarterly revenue growth grew by 44.4%, now sitting on 35.28M for the twelve trailing months.
Volume
Today's last reported volume for iRadimed Corporation is 4373 which is 81.51% below its average volume of 23656.
iRadimed Corporation's sales growth for the next quarter is 25.8%. The company's growth estimates for the ongoing quarter and the next is 54.5% and 142.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.41%.
Volatility
iRadimed Corporation's last day, last week, and last month's current volatility was 0.05%, 0.68%, and 1.57%, respectively.
iRadimed Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.27% (day), 2.50% (last week), and 3.64% (last month), respectively.
iRadimed Corporation's Stock Yearly Top and Bottom Value
iRadimed Corporation's stock is valued at $36.76 at 06:22 EST, under its 52-week high of $40.51 and way above its 52-week low of $21.63.
iRadimed Corporation's Moving Average
iRadimed Corporation's worth is higher than its 50-day moving average of $34.75 and way higher than its 200-day moving average of $31.28.3. ArcBest Corporation (ARCB)
20.7% sales growth and 16.45% return on equity
ArcBest Corporation provides freight transportation and integrated logistics services.
ArcBest Corporation's sales growth this year is expected to be 28.4% and 18.7% for next year.
Year-on-year quarterly revenue growth grew by 51.3%, now sitting on 3.39B for the twelve trailing months.
Volume
Today's last reported volume for ArcBest Corporation is 226529 which is 27.34% below its average volume of 311790.
ArcBest Corporation's sales growth is a negative 0% for the current quarter and 20.7% for the next. The company's growth estimates for the present quarter and the next is 100.8% and 83.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.45%.
Volatility
ArcBest Corporation's last day, last week, and last month's current volatility was 0.75%, 2.12%, and 2.30%, respectively.
ArcBest Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.10% (day), 3.68% (last week), and 4.18% (last month), respectively.
ArcBest Corporation's Stock Yearly Top and Bottom Value
ArcBest Corporation's stock is valued at $85.34 at 06:22 EST, under its 52-week high of $93.96 and way higher than its 52-week low of $29.02.
ArcBest Corporation's Moving Average
ArcBest Corporation's worth is way higher than its 50-day moving average of $77.56 and way higher than its 200-day moving average of $70.34.4. BioDelivery Sciences International (BDSI)
9.8% sales growth and 34.1% return on equity
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally.
BioDelivery Sciences International's sales growth this year is anticipated to be 9.2% and 26.5% for next year.
Year-on-year quarterly revenue growth grew by 13.3%, now sitting on 164.07M for the twelve trailing months.
Volume
Today's last reported volume for BioDelivery Sciences International is 535131 which is 23.71% below its average volume of 701496.
BioDelivery Sciences International's sales growth for the next quarter is 9.8%. The company's growth estimates for the ongoing quarter and the next is a negative 44.4% and negative -40%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.1%.
Volatility
BioDelivery Sciences International's last day, last week, and last month's current volatility was 0.24%, 1.41%, and 2.26%, respectively.
BioDelivery Sciences International's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.95% (day), 2.96% (last week), and 4.05% (last month), respectively.
BioDelivery Sciences International's Stock Yearly Top and Bottom Value
BioDelivery Sciences International's stock is valued at $4.14 at 06:22 EST, way below its 52-week high of $4.99 and way higher than its 52-week low of $3.04.
BioDelivery Sciences International's Moving Average
BioDelivery Sciences International's worth is higher than its 50-day moving average of $3.92 and way above its 200-day moving average of $3.68.5. Casella Waste Systems (CWST)
9.2% sales growth and 36.26% return on equity
Casella Waste Systems, Inc., together with its subsidiaries, operates as a vertically integrated solid waste services company in the northeastern United States.
Casella Waste Systems's sales growth this year is anticipated to be 9.5% and 7.9% for next year.
Year-on-year quarterly revenue growth grew by 14.4%, now sitting on 808.31M for the twelve trailing months.
Volume
Today's last reported volume for Casella Waste Systems is 196757 which is 4.11% below its average volume of 205207.
Casella Waste Systems's sales growth for the next quarter is 9.2%. The company's growth estimates for the ongoing quarter and the next is a negative 27% and negative -5.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 36.26%.
Volatility
Casella Waste Systems's last day, last week, and last month's current volatility was 0.51%, 0.92%, and 1.00%, respectively.
Casella Waste Systems's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.33% (day), 1.58% (last week), and 2.10% (last month), respectively.
Casella Waste Systems's Stock Yearly Top and Bottom Value
Casella Waste Systems's stock is valued at $81.17 at 06:22 EST, below its 52-week high of $82.29 and way higher than its 52-week low of $53.43.